title: Highly active dimeric and low-activity tetrameric forms of selenium-containing rat thioredoxin reductase 1.
abstract: Mammalian thioredoxin reductase 1 (TrxR1) is a selenoprotein that contains a selenocysteine (Sec) residue at the penultimate C-terminal position. When rat TrxR1 is expressed recombinantly in Escherichia coli, partial truncation at the Sec-encoding UGA gives rise to additional protein species that lack Sec. Phenylarsine oxide (PAO) Sepharose can subsequently be used to enrich the Sec-containing protein and yield activity corresponding to that of native enzyme. Herein we extensively purified recombinant rat TrxR1 over PAO Sepharose, which gave an enzyme with about 53 U/mg specific activity. Surprisingly, only about 65% of the subunits of this TrxR1 preparation contained Sec, whereas about 35% were protein products derived from UGA truncation. Further analyses revealed a theoretical maximal specific activity of 70-80 U/mg for the homodimeric enzyme with full Sec content, i.e., significantly higher than that reported for native TrxR1. We also discovered the formation of highly stable noncovalently linked tetrameric forms of TrxR1, having full FAD content but about half the specific activity in relation to the selenium content compared to the dimeric protein. The characterization of these different forms of recombinant TrxR1 revealed that inherent turnover capacity of the enzyme must be revised, that multimeric states of the protein may be formed, and that the yield of bacterial selenoprotein production may be lower than earlier reported. The biological significance of the hitherto unsurpassed high specific activity of the enzyme involves the capacity to support a higher turnover in vivo than previously believed. The tetrameric forms of the protein could represent hitherto unknown regulatory states of the enzyme.
authors.affiliation: Division of Biochemistry, Medical Nobel Institute for Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
authors.forename: Olle
authors.initials: O
authors.lastname: Rengby
authors.forename: Qing
authors.initials: Q
authors.lastname: Cheng
authors.forename: Marie
authors.initials: M
authors.lastname: Vahter
authors.forename: Hans
authors.initials: H
authors.lastname: Jörnvall
authors.forename: Elias S J
authors.initials: ES
authors.lastname: Arnér
mesh_terms: D000818:Animals; D001152:Arsenicals / Q000737:chemistry / Q000378:metabolism; D003001:Cloning, Molecular; D018388:Codon, Terminator / Q000502:physiology; D003545:Cysteine / Q000737:chemistry; D004789:Enzyme Activation; D004926:Escherichia coli; D016297:Mutagenesis, Site-Directed; D055503:Protein Multimerization; D051381:Rats; D011994:Recombinant Proteins; D012643:Selenium / Q000737:chemistry / Q000378:metabolism*; D012685:Sepharose; D013379:Substrate Specificity; D054481:Thioredoxin Reductase 1 / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D001152:Arsenicals; D018388:Codon, Terminator; D011994:Recombinant Proteins; C029341:oxophenylarsine; D012685:Sepharose; D054481:Thioredoxin Reductase 1; D012643:Selenium; D003545:Cysteine